Literature DB >> 5971797

The biochemistry of aromatic amines. The metabolism of 2-naphthylamine and 2-naphthylhydroxylamine derivatives.

E Boyland, D Manson.   

Abstract

1. 2-Naphthylhydroxylamine and 2-nitrosonaphthalene were present in urine of dogs but not of guinea pigs, hamsters, rabbits or rats dosed with 2-naphthylamine. N-Acetyl-2-naphthylhydroxylamine and its O-sulphonic acid and O-glucosiduronic acid were not detected in the urine of any of these species. 2. Bile from rats dosed with 2-naphthylamine contained (2-naphthylamine N-glucosid)uronic acid and 6- and 5,6-substituted derivatives of 2-acetamidonaphthalene. 2-Amino-1-naphthyl and 2-acetamido-1-naphthyl derivatives, 2-naphthylhydroxylamine and its N-acetyl derivative or conjugates of these were not detected. Bile from a dog dosed with 2-naphthylamine contained no 2-amino-1-naphthyl derivatives. 3. 2-Naphthylhydroxylamine was metabolized by the dog, rat and guinea pig to the same products as those formed by these species from 2-naphthylamine. Rabbits formed mainly 2-amino-1-naphthyl derivatives; these are minor metabolites of 2-naphthylamine in this species. 4. (N-Acetyl-2-naphthylhydroxylamine O-glucosid)uronic acid was excreted in the urine and the bile of rats and in the urine of guinea pigs and rabbits dosed with N-acetyl-2-naphthylhydroxylamine. 5. After the administration of 2-acetamidonaphthalene, (N-acetyl-2-naphthylhydroxylamine O-glucosid)uronic acid was detected in the urine of dogs, but not in the urine of other species. The dog excreted an acid-labile cysteine derivative of 2-acetamidonaphthalene, but only traces of the corresponding mercapturic acid. 6. After dosing with N-acetyl-2-naphthylhydroxylamine-O-sulphonic acid, rats excreted derivatives of 2-amino-1-naphthol. 7. 2-Nitrosonaphthalene, N-acetyl-2-naphthylhydroxylamine, N-acetyl-2-naphthylhydroxylamine-O-sulphonic acid, 2-naphthylhydroxylamine-N-sulphonic acid, N-benzyloxycarbonyl-2-naphthylhydroxylamine and N-benzyloxycarbonyl-2-naphthylhydroxylamine-O-sulphonic acid were synthesized.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5971797      PMCID: PMC1270069          DOI: 10.1042/bj1010084

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  The N- and ring-hydroxylation of 2-acetylaminofluorene and the failure to detect N-acetylation of 2-aminofluorene in the dog.

Authors:  L A POIRIER; J A MILLER; E C MILLER
Journal:  Cancer Res       Date:  1963-06       Impact factor: 12.701

2.  An experimental inquiry into the cause of industrial bladder cancer.

Authors:  G M BONSER; D B CLAYSON; J W JULL
Journal:  Lancet       Date:  1951-08-18       Impact factor: 79.321

3.  Deacetylation of acetamido compounds by tissue extracts.

Authors:  H G BRAY; S P JAMES; W V THORPE; M R WASDELL
Journal:  Biochem J       Date:  1950-10       Impact factor: 3.857

4.  The biochemistry of aromatic amines. 8. Synthesis and detection of di-(2-amino-1-naphthyl) hydrogen phosphate, a metabolite of 2-naphthylamine in dogs.

Authors:  E Boyland; C H Kinder; D Manson
Journal:  Biochem J       Date:  1961-01       Impact factor: 3.857

5.  Aromatic amines. III. Note on bis (2-amino-1-naphthyl) phosphate, a urinary metabolite of 2-naphthylamine.

Authors:  W TROLL; S BELMAN; N NELSON
Journal:  Proc Soc Exp Biol Med       Date:  1959-01

6.  The biochemistry of aromatic amines. 5. 2-Aceta-mido-6-hydroxy-5-naphthyl hydrogen sulphate and other metabolites of 2-naphthylamine and 2-aceta-midonaphthalene.

Authors:  E BOYLAND; D MANSON
Journal:  Biochem J       Date:  1958-08       Impact factor: 3.857

7.  The biochemistry of aromatic amines. 7. The enzymic hydrolysis of aminonaphthyl glucosiduronic acids.

Authors:  E BOYLAND; K WILLIAMS
Journal:  Biochem J       Date:  1960-08       Impact factor: 3.857

8.  Cancer of the urinary bladder induced in mice with metabolites of aromatic amines and tryptophan.

Authors:  M J ALLEN; E BOYLAND; C E DUKES; E S HORNING; J G WATSON
Journal:  Br J Cancer       Date:  1957-06       Impact factor: 7.640

9.  Carcinogenicity of 2-naphthylhydroxylamine and 2-naphthylamine.

Authors:  E BOYLAND; C E DUKES; P L GROVER
Journal:  Br J Cancer       Date:  1963-03       Impact factor: 7.640

10.  A further study of the carcinogenic properties of ortho hydroxy-amines and related compounds by bladder implantation in the mouse.

Authors:  G M BONSER; L BRADSHAW; D B CLAYSON; J W JULL
Journal:  Br J Cancer       Date:  1956-09       Impact factor: 7.640

View more
  7 in total

1.  The role of N-oxidation products of aromatic amines in the induction of baldder cancer in the dog.

Authors:  J L Radomski; E Brill
Journal:  Arch Toxikol       Date:  1971

Review 2.  [The activation of carcinogenic aromatic amines in metabolism].

Authors:  H G Neumann
Journal:  Klin Wochenschr       Date:  1970-08-15

Review 3.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

Review 4.  Structural analysis as a means of predicting carcinogenic potential.

Authors:  J Ashby
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

5.  Isolation of 2-amino-1-naphthyl hydrogen sulphate with cetylpyridinium bromide from metabolic and chemical oxidations of 2-naphthylamine.

Authors:  D Manson
Journal:  Biochem J       Date:  1970-09       Impact factor: 3.857

6.  [Importance of chemico-biological interactions for the toxic and carcinogenic effect of aromatic amines. IV. Metabolic patterns of trans-4-demethylaminostilbene, cis-4-dimethylaminostilbene and 4-dimethylaminobibenzyl in liver, kidney and excretion products of the rat].

Authors:  M Metzler; H G Neumann
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1971

7.  The oxidation of some carcinogenic arylhydroxylamines to nitroso derivatives with manganese dioxide.

Authors:  E Brill
Journal:  Experientia       Date:  1974-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.